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Abstract
Streptococcus pneumoniae is a significant pathogen in children. Although the
PCV7 pneumococcal conjugate vaccine has reduced pneumococcal disease,
non-vaccine serotype 19A infection has increased, despite expectations of
cross-protection from vaccine serotype 19F. Serotype 19A is included in the
new PCV13 vaccine, but not in PCV10.
In the solution simulations of 19F and 19A oligosaccharide chains reported
here, both polysaccharides form unstructured random coils, with inflexible re-
peat units linked by mobile phosphodiester linkages. However, there are clear
conformational differences. In the 19F repeat unit, the rhamnose residue is
nearly orthogonal to the other residues, whereas 19A has residues in simi-
lar orientations. This finding is corroborated by key inter-residue distances
calculated from NMR NOESY experiments. Further, 19F is predominantly
in extended conformations, whereas 19A exhibits a high prevalence of tight
hairpin bends.
These conformational differences may account for a lack of antibody cross-
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protection between serotypes 19F and 19A.
Keywords: Streptococcus pneumoniae, vaccine, pneumococcal, cross
protection, Molecular Modelling
1. Introduction
The capsular polysaccharides of pneumococci are essential for bacterial
virulence; vaccine-induced serum antibodies against capsular polysaccharides
confer resistance to pneumococcal disease. Pneumococcal serogroup 19 is
currently responsible for the bulk of pneumococcal disease. Within serogroup
19, which comprises serotypes 19F, 19A, 19B and 19C, disease is caused
chiefly by 19A and 19F1:
→4)-β-d-ManpNAc-(1→4)-α-d-Glcp-(1→2)-α-l-Rhap-(1-P→
19F capsular polysaccharide
→4)-β-d-ManpNAc-(1→4)-α-d-Glcp-(1→3)-α-l-Rhap-(1-P→
19A capsular polysaccharide
While serotypes 19F and 19A have very similar trisaccharide repeating
units, cross-protection for these serotypes has not been clearly demonstrated:
the 7-valent Prevnar vaccine (PVC7) contains 19F, but does not appear to
elicit clinically meaningful cross-protection against 19A invasive pneumococ-
cal disease2. Indeed, despite current widespread vaccination with 19F in
PCV7, the proportion of infections caused by serotype 19A has increased:
currently, 19A appears to be the most prevalent and antibiotic-resistant
pneumococcal serotype3,4. This apparent lack of cross-protection for 19F
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and 19A is in agreement with early studies published for the pneumococ-
cal polysaccharide vaccines: although the 19F polysaccharide vaccine raised
cross-reactive antibodies against 19A, they displayed low functionality in the
opsonophagocytic killing assay.5 This assay is currently used as a surrogate
assessment of the clinical efficacy of pneumococcal conjugate vaccines6; the
opsonic ability of antibodies has been correlated to their avidity in pre-clinical
studies7. These studies led to the inclusion of the serotype 19A polysac-
charide in the second-generation 23-valent vaccine8,9. The higher valency
conjugate vaccine PCV13, which aims to provide greater coverage of the
emerging pneumococcal strains, also contains both serotypes 19F and 19A.
Immunogenicity studies for PCV13 showed the presence of functional anti-
body activity predictive of protection against serotype 19A disease10, which
has been confirmed by recent post-licensure studies11. In contrast, while the
PCV10 vaccine does not contain serotype 19A, indirect protection against
19A is claimed based on the conjugation chemistry employed in PCV10 for
the serotype 19F-diphtheria toxoid vaccine component12,13. However, in our
opinion, this is doubtful, as the random activation chemistry utilising cyany-
lation (PVC10) or periodate oxidation (PCV13) relies on levels of activation
that are sufficient to permit conjugation, but low enough so as not to affect
the structural integrity of the native polysaccharide antigen.
In this work, we continue our systematic investigation of the molecular
basis of cross protection in pneumococcal serotypes 19F and 19A which we
began with simulation of the conformation of the repeating units in the carbo-
hydrate antigens14. This first study predicted a wider range of conformations
for 19F than the more constrained 19A trisaccharide, suggesting a probable
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conformational difference between the polysaccharides. Here we extend this
investigation to solution simulations of 19F and 19A oligosaccharide chains
comprising three- and six repeat units, as well as experimental NMR NOESY
measurements on the 19F and 19A polysaccharides.
2. Experimental Section
We analyse the 19F and 19A pneumococcal polysaccharides according to
the following glycosidic linkages and corresponding abbreviations.
Linkage Abbreviation Polysaccharide
β-d-ManpNAc-(1→4)-α-d-Glcp M14G 19F and 19A
α-l-Rhap-(1-P→4)-β-d-ManpNAc RP4M 19F and 19A
α-d-Glcp-(1→2)-α-l-Rhap G12R 19F
α-d-Glcp-(1→3)-α-l-Rhap G13R 19A
The two-bond (1→X) glycosidic linkages in M14G, G12R and G13R are de-
fined by the torsion angles φ = H1′–C1′–O–CX and ψ = C1′–O–CX–HX.
These definitions for φ and ψ are analogous to φH and ψH in IUPAC con-
vention. In the case of the RP4M phosphodiester linkage, the four dihedral
angles are defined as φ = H1′–C1′–O–P , ψ = C1′–O–P–O, ω = O–P–O–C4
and  = P–O–C4–H4.
2.1. Molecular Dynamics Simulations
All simulations were performed with the NAMD molecular dynamics
program15 version 2.9 (employing NAMD CUDA extensions for calculation
of long-range electrostatics and nonbonded forces on graphics processing
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units16) and run on a 12 core, 4 TeslaM2090 GPU server with 64GB RAM
per core and 6GB DDR5 per GPU.
Water was simulated with the TIP3P model17. Carbohydrates were mod-
eled with the CHARMM36 additive force field for carbohydrates,18,19 with
ad hoc extensions for the phosphodiester linkage, as follows. Although pa-
rameters for phosphate substituents were recently added to the CHARMM
carbohydrate force field20, these do not yet extend to flexible anomeric phos-
phodiester linkages. Therefore, this work necessitated adjustments to the
CHARMM carbohydrate force field to represent the β-d-ManpNAc residue,
as well as the α(P→4) glycosidic phosphodiester linkage for pyranose rings.
In accordance with suggestions from the lead CHARMM force field devel-
oper, the ManNAc residue was adapted from the parameters in the existing
βMan and αGlcNAc residues and bond, angle and dihedral parameters for
the phosphodiester linkages were taken from similar linkages in the existing
force field, or from the CHARMM nucleic acid force field where necessary21.
Initial configurations of the three- and six repeating unit oligosaccharides
(hereafter termed RU3 and RU6) for both 19F and 19A were built using
our in-house software CarbBuilder22, which employs the psfgen23 tool to
create “protein structure”(psf) files for modelling with a specified CHARMM
force field and the NAMD molecular dynamics program. Using CarbBuilder,
the glycosidic linkage dihedrals were set to initial values within the global
energy minima previously identified14: φ,ψ = 51◦,−6◦ for the M14G linkage,
φ,ψ = −41◦,−24◦ for the G12R linkage (19F) and φ,ψ = −28◦, 43◦ for the
G13R linkage (19A). The phosphodiester linkage, α-l-Rhap-(1-P→4)-β-d-
ManpNAc, was set to φ, ψ, ω,  = −50◦, 180◦,−180◦,−180◦ to produce initial
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extended structures.
These initial oligosaccharide structures were optimised through 1000 steps
of standard NAMD minimization in vacuum and then solvated (using the sol-
vate plugin to the Visual Molecular Dynamics (VMD)24 analysis package) in
a periodic cubic unit cell with randomly distributed sodium ions to electro-
statically neutralize the system: the RU3 structures used a 60 × 60 × 60 A˚
cube and three sodium ions, while the RU6 structures used a 110 × 110 ×
110 A˚ cube and six sodium ions.
The RU3 MD simulations ran for 150 ns and the larger, computationally
expensive RU6 simulations for 100 ns. All MD simulations were preceded by a
30 000 step minimisation phase, with a temperature control and equilibration
regime involving 10 K temperature reassignments from 10 K culminating
in a maximum temperature of 300 K. Equations of motion were integrated
using a Leap-Frog Verlet integrator with a step size of 1 fs and periodic
boundary conditions. Simulations were performed under isothermal-isobaric
(nPT) conditions at 300 K maintained using a Langevin piston barostat25
and a Nose-Hoover26,27 thermostat.
Long-range electrostatic interactions were treated using particle mesh
Ewald (PME) summation, with κ = 0.20 A˚−1 and PME grid dimensions
of 60 for the RU3 systems and 110 for the RU6 systems. Non-bonded inter-
actions were truncated with a switching function applied between 12.0 and
15.0 A˚ to groups with integer charge. The 1-4 interactions were not scaled,
in accordance with the CHARMM force field recommendations.
Subsequent analysis of the simulations used time series frames 25 ps apart.
Molecular conformations extracted from the MD simulations were depicted
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with VMD, where necessary using the PaperChain visualization algorithm
for carbohydrates28 to highlight the glycan rings. For comparison with NMR
measurements, average effective proton-proton distances, r, were calculated
from the equilibrated RU3 simulations using the equation
r = < r−6i,j >
− 1
6 (1)
where ri,j is the instantaneous atomic distance between atoms i and j. The
radius of gyration, Rg, is a common measure of the conformation of a polymer
and represents the root-mean-square distance of a collection of atoms from
their common centre of mass. We calculated Rg with VMD using the carbon
atoms in each oligosaccharide chain as:
Rg
2 =
1
n
n∑
i=1
(Ri −Rc)2 (2)
where Rc is the centre of mass, Ri the position of atom i and n the number
of atoms. The squared end-to-end distances, d2, were measured as
d2 = (RC2 −RC4)2 (3)
where RC4 is the position of the carbon atom C4 on the first ManNAc residue
and RC2 is the position of the carbon atom C2 (or C3 for the 19A oligosac-
charide) on the rhamnose at the terminal reducing end.
Conformations from both RU3 trajectories were clustered using VMD’s
internal measure cluster command to calculate clusters according to the qual-
ity threshold algorithm.29 Clustering was performed with a cut-off of 3.0 on
an RMSD fit to the carbon, oxygen and phosphate atoms involved in the
glycosidic linkages.
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2.2. NMR
19F and 19A polysaccharide samples were obtained from PATH’s pneu-
mococcal vaccine project. The samples (10 mg) were dissolved in D2O (0.6
mL, Aldrich) and transferred to 5 mm NMR tubes (Wilmad). NMR spec-
tra were obtained using a Bruker Avance III 600 MHz NMR spectrometer
equipped with a BBO Prodigy cryoprobe. The probe temperature was set at
303 K and the spectra were acquired and processed using standard Bruker
software (Topspin 3.2). 1H NMR spectra were referenced to the residual cell
wall polysaccharide signal at 3.23 ppm. Two dimensional NMR spectra were
collected in the phase sensitive mode, TOCSY (mixing time, 120 ms) and
NOESY (mixing time, 250 ms) using presaturation to suppress the water
resonance. Spectral assignments were based on literature assignments and
confirmed by use of 1H-1H and 1H-13C correlation experiments30,31. Linearity
of the NOE build-up curves was demonstrated using a series of 1D NOE ex-
periments (mixing times ranging from 100 to 400 ms). Inter-proton distances
were estimated from the integrated cross-peak intensities of key 2D NOESY
peaks by the isolated spin pair approximation32:
ri,j = rref
(
aref
aij
) 1
6
(4)
where ri,j is the inter proton distance to be estimated and aij the correspond-
ing cross-peak intensity. The ManNAc H1/ManNAc H3 distance calculated
from the RU3 solution simulation (2.38 A˚, an r6 average) was used as a
reference distance.
8
M14G
G
M R
M
G
R
M
G
R
R
M G
M14G
RU6
RU1
M G R
G12R
19F 19A
G13R
G
RU3
M R
−120
−60
 0
 60
 120
−60
−120
ψ
ψ
ψ
−120 −60  0  60  120
φ
−120 −60  0  60  120
φ
−120 −60  0  60  120
−120
φ
−120 −60  0  60  120
φ
 120
 60
−60
 0
 0
 60
 120
Figure 1:
3. Results and discussion
We begin our analysis of the pneumococcal capsular polysaccharides in
serotypes 19F and 19A with investigation of the conformation and dynam-
ics of the repeat unit and then progress to the preferred conformation and
dynamics of the RU3 and RU6 polysaccharide chains.
3.1. Repeating unit conformation
The repeating units in the RU3 and RU6 polysaccharides remain rel-
atively rigid in solution, as is clear from a comparison of the M14G and
G12R/G13R dihedral angle time series for RU1 (prior work14), RU3 and
RU6 simulations shown in Figure 1.
Comparison across the RU1, RU3 and RU6 simulations in Figure 1 reveals
that additional RU do not affect the distribution of dihedral angle values sig-
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nificantly. This indicates that, for both the 19F and the 19A polysaccharides,
the RU1 simulations give a good indication of the dihedral angle distribution
in the corresponding polymer. The mean φ, ψ values for the 19F G12R link-
age in the RU3 simulations are φ, ψ = -45.63◦ (15.28), -30.50◦ (27.50), while
for the 19A G13R linkage φ, ψ = -53.84◦ (13.30), -42◦ (26.50). However, the
19F repeating unit is more conformationally varied than the 19A repeating
unit: while the 19A shows a normal distribution about the mean for both φ
and ψ, 19F has two minor populations at ψ > 0◦ (≈ 10%) and ψ < 90◦ (≈
10%). This is in accordance with our detailed analysis of the single repeating
units in 19F and 19A, which showed two families of “bent” conformations
for the G12R linkage, that are not apparent in the G13R linkage.14
In these comparatively rigid repeat units, across all simulations there is
a marked difference in the relative orientation of the Rha residue in 19F
as compared to 19A. In 19F, the orientation of the plane of Rha is nearly
orthogonal to the Glc and ManNAc residues, whereas in 19A the planes of the
sugar rings are all in roughly parallel orientations - compare representative
conformations of 19F (Figure 2, left) and 19A (Figure 2 left) repeat units.
A direct measure of this difference relative orientation of the Rha are the
inter-residue H1 Glc/H1 Rha and H1 Glc/H3 Rha distances. Figure 2 shows
a time series plot of these distances for the middle residue in the RU3 unit
simulations of 19F (red) and 19A (green) (RU1 and RU6 simulations show
the same distribution). 19F and 19A show distinct, separate populations for
these distances (Figure 2, middle). The orthogonal arrangement of Rha in
19F brings the Glc H1 atom into close proximity with the Rha H1 atom,
while stretching the H1 Glc/H3 Rha distance (representative structure with
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Table 1:
19F 19A
Atomic distance (A˚) exp. sim. exp. sim.
H1 Glc/H1 Rha 2.32 2.28 - 4.68
H1 Glc/H2 Rha 2.49 2.41 2.44 2.25
H1 Glc/H3 Rha - 4.57 2.81 2.66
H1 ManNAc/H4 Glc 2.33 2.30 2.19 2.31
distances indicated shown in Figure 2, left). The opposite holds for 19A:
Glc H1 is in close proximity to Rha H3, but relatively distant from Rha H1
(representative structure with distances indicated shown in Figure 2, right).
In contrast, the Glc H1/Rha H2 distance is similar for both the 19F and 19A
repeat units.
This finding is corroborated by our NMR NOESY experiments (Figure
3). The H1 Glc/H2 Rha peak is present in NOESY for both 19F and 19A
(indicating close proximity of these atoms in the polysaccharides), but the
H1 Glc/H3 Rha peak is absent in the 19F NOESY and the H1 Glc/H1 Rha
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peak is absent in the 19A NOESY. Further, the distances calculated by peak
integration (Table 1) show good agreement between simulation and NMR.
3.2. Polymer hydrodynamics
Although the repeat units are relatively rigid, in our simulations, the
three repeat unit (RU3) oligomers for 19F and 19A polymers are very mobile
- a consequence of the very flexible phosphodiester linkage. In both 19F
and 19A, the peripheral φ and  torsions for the phosphodiester linkage are
constrained to conformations in the range −60◦ to +50◦. Rotations about
the phosphodiester linkage are therefore primarily determined by the central
phosphodiester linkage dihedrals: ψ and ω. These C-O-P-O dihedrals each
have three principal minimum energy conformations: −85◦, 85◦ and 175◦.
Although transitions between these minima occur frequently through the
simulations, both 19A and 19F favour the ψ, ω = −85◦,−85◦ conformation,
which causes a bend in the phosphodiester bond. However, 19F shows an
increased population of the secondary minimum conformation ψ, ω = 85◦, 85◦
which is associated with extension of the phosphodiester linkage.
The RU3 simulations demonstrate that the 19F and 19A R are mo-
bile, disorganised molecules that form random coils, with no well-defined
tertiary structure. There is a wide variation in Rg for both the 19F and
19A molecules (Figure 4i), which alternate between extended and compact
conformations throughout the 150 ns of simulation time. However, the RU3
simulations show a difference in average Rg (indicated by the dashed lines
in the graph Figure 4i): after discarding the first 10 ns as equilibration, 19F
has < Rg >=10.43(1.12) A˚, while 19A has < Rg >=9.07(1.37) A˚. As a fur-
ther comparison, for the same period the 19F RU3 oligomer shows a mean
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squared end-to-end distance of 823 A˚2, while 19A has 474 A˚2. 19F has a
higher frequency of extended structures (Figure 4i, conformations C and E),
19A more persistent compact structures (Figure 4i, conformations c and d).
This behaviour is a direct consequence of the different repeat unit confor-
mations for 19F and 19A, as follows. The parallel arrangement of residues
in 19A allows for close stacking of residues in successive RU’s in tight hair-
pin bends about the phosphodiester linkage (e.g. Figure 4i conformation a).
This allows for strong shifting network of Glc-Glc’ or Glc-ManNAc’ hydro-
gen bonds, an example of which is shown in Figure 4ii, where an Glc HO6 -
ManNAc’ O2 hydrogen bond is formed across the bend. These interactions
maintain the hairpin bend for up to 20 ns (e.g. conformation c in Figure
4i). Indeed, our clustering analysis reveals that the 19A RU3 strand is in
a hairpin bend conformation about one of the two internal phosphodiester
linkages for approximately 75% of simulation time. In contrast, while hairpin
bends do occur for 19F (e.g. conformation B in Figure 4i), they do not bring
successive RUs into as close enough proximity for hydrogen bonding and are
therefore comparatively short-lived: the 19F RU3 strand is in hairpin bend
conformations for only 6% of the simulation, while very extended conforma-
tions (e.g. conformation C in Figure 4i) occur for 25% of the simulation
time.
The autocorrelations of Rg for the RU3 strands indicate relative long
decay times of ≈ 5-10 ns (Figure 4iii), with 19A having the longer decay.
These extended decay times are a result of entanglements promoted by self-
interactions between methyl, hydroxymethyl and N-acetyl groups on neigh-
bouring repeating units in both 19F and 19A. The longer decay for 19A is a
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consequence of the close residue stacking that facilitates hairpin bends. This
propensity for self-entanglements has the consequence that, after 100 ns of
simulation time, the computationally expensive simulations of RU6 of 19F
and 19A cannot be said to have reached equilibrium with regards to chain
conformation, as is evident from theRg time series for these molecules (Figure
5i). However, it is also clear that the hydrodynamic behaviour of the longer
RU6 strands is consistent with the corresponding RU3 simulations, with con-
stant interconversions between compact and extended structures (compare
structures A-E and a-e in Figure 5i). Also, although the simulations have
not equilibrated, the 19F simulation shows Rg values associated with more
extended structures, whereas the trend of the 19A simulation is towards more
compact conformations. Once more, long-lived hairpin bends are prevalent
for the 19A oligosaccharide: Figure 5iii shows an example hairpin conforma-
tion, with Glc-Glc’ and ManNAc’-Glc hydrogen bonds stabilizing the bend.
4. Conclusions
Although polymer dynamics in our simulations of the 19F and 19A pro-
vides evidence of very mobile random chains for both molecules, this is a
consequence of the very flexible phosphodiester linkage: both the 19F and
19A repeating units are relatively rigid. Most significant, there is a marked
difference in the repeating unit conformation of 19F and 19A, with 19F
having Rha oriented nearly orthogonal to the Glc and ManNAc residues,
whereas 19A has the planes of the sugar rings in parallel orientations. This
finding is corroborated by NMR NOESY experiments, with distances from
peak integration in good agreement with simulation distances. Further, in
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our simulations, the 19F oligosaccharide adopts more extended conforma-
tions than 19A: tight hairpin bends around the phosphodiester linkage are
favoured in 19A by the close stacking of successive repeating units allowed
by the Glcα(1→3)Rha linkage. These structural differences could account
for the lack of cross-protection of serotype 19F vaccination against serotype
19A disease.
Therefore, we have shown that a slight difference in glycosidic linkage
conformation can have a significant affect, not only the conformation of the
repeating unit, but the polysaccharide as a whole. We are extending our sys-
tematic approach — analysis of the carbohydrate backbone from individual
disaccharide pairs to 6RU chains — to the study of closely related bacterial
capsular polysaccharide serotypes where similar structures of the capsular
polysaccharide repeating unit also elicit distinct immune responses.
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Figure and Table Captions
Table 1. Inter-atomic distances (A˚) for 19F and 19A from NMR and simu-
lation.
Figure 1. Plots for 19F (left, red) and 19A (right, green) of the M14G
and G12R/G13R φ,ψ simulation time series superimposed on the cor-
responding disaccharide vacuum free energy surfaces14 for RU1 (top,
prior work14), RU3 (middle) and RU6 (bottom). The first 10 ns of
simulation were discarded as equilibration. RU3 shows time series for
the middle repeating unit only (highlighted in the structures); RU6
the time series for repeating units 3 and 4 (also highlighted in the cor-
responding structures). Structures are annotated to indicate residue
identity: ManNAc (M, green), Glc (G, blue) and Rha (R, purple).
Figure 2. Time series of the H1 Glc/H1 Rha and H1 Glc/H3 Rha distances
for the middle repeat unit in the RU3 simulations of 19F (red, top and
left) and 19A (green, bottom and right). Distances from NMR are in-
dicated by dashed lines. Representative conformations for the middle
RU are shown for 19F (left) and 19A (right), with key atoms and dis-
tances indicated. Structures are annotated to indicate residue identity:
ManNAc (M, green), Glc (G, blue) and Rha (R, purple).
Figure 3. Selected regions of the 2D 1H-1H-NOESY spectra of polysaccha-
ride serotype 19F (A) and 19A (B) recorded at 1H frequency of 600
24
MHz and with a mixing time of 250 ms. Key correlations from the
anomeric protons are annotated.
Figure 4. Comparison of the hydrodynamic behaviour of the RU3 19F and
19A polysaccharides. i) Time series of the instantaneous values of the
radius of gyration (A˚) for the RU3 simulations of the 19F (red line, top)
and 19A (green line, bottom) polysaccharides. Representative struc-
tures are shown (19F top and 19A bottom) and the average radius
of gyration indicated dashed lines. ii) Snapshot at 84 ns of a hairpin
bend in 19A RU3, showing stabilizing hydrogen bonding interactions
(dashed lines) between adjacent repeat units. iii) Time autocorrelation
function for the radius of gyration for the RU3 simulations in 19F (red
line) and 19A (green line).
Figure 5. Comparison of the hydrodynamic behaviour of the RU6 19F and
19A polysaccharides. i) Time series of the instantaneous values of the
radius of gyration (A˚) for the RU6 simulations of the 19F (red line, top)
and 19A (green line, bottom) polysaccharides. Representative struc-
tures are shown (19F top and 19A bottom). ii) Closeup at 84 ns of a
hairpin bend in 19A, showing stabilizing hydrogen bonding interactions
(dashed lines) between adjacent repeat units.
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